Document Detail


Adducts of acrylonitrile with hemoglobin in nonsmokers and in participants in a smoking cessation program.
MedLine Citation:
PMID:  10525260     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hemoglobin adducts have been used to assess exposure to carcinogenic compounds in tobacco smoke. However, because of background levels in nonsmokers, most adducts that have been studied are not useful for monitoring low-level exposure. Bergmark [(1997) Chem. Res. Toxicol. 10, 78-84] showed that the level of adducts of acrylonitrile (AN) with N-terminal valine (ANVal) increases with increasing cigarette consumption, and the increment from 1 cigarette/day was estimated to be 8 pmol/g of globin. The background level of ANVal in nonsmokers was not quantified (<2 pmol/g of globin). The objective of this study was to determine the background level of ANVal in hemoglobin and to study the stability of this adduct in vivo. Globin samples previously analyzed by Bergmark from 17 nonsmokers and 2 smokers were reanalyzed in the study presented here. Globin samples from 7 additional nonsmokers and from 10 participants in a smoking cessation program were also analyzed. Smoking habits and exposure to environmental tobacco smoke (ETS) were assessed by interview. Only two of the participants completed the program. The levels of ANVal in these 2 subjects decreased after quitting and were at background level by 126 days. The time course of the decrease was compatible with removal of stable adducts. The levels of ANVal in the nonsmokers were 0.76 +/- 0.36 (mean +/- SD) (n = 18; reporting no exposure ETS), 1.1 +/- 0.6 (n = 3; reporting exposure to ETS), and 1. 2 +/- 0.5 pmol/g of globin (n = 3; snuff users). Thus, the adduct level in nonsmokers corresponds to the adduct increment from about 0. 1 cigarette/day. Measurements of the level of ANVal could be used to distinguish between nonsmokers and low-level smokers on an individual level, but larger groups of individuals would be required to detect a possible contribution to the background from passive smoking.
Authors:
H L Pérez; D Segerbäck; S Osterman-Golkar
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chemical research in toxicology     Volume:  12     ISSN:  0893-228X     ISO Abbreviation:  Chem. Res. Toxicol.     Publication Date:  1999 Oct 
Date Detail:
Created Date:  2000-01-04     Completed Date:  2000-01-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8807448     Medline TA:  Chem Res Toxicol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  869-73     Citation Subset:  IM    
Affiliation:
Department of Molecular Genome Research, Stockholm University, SE-106 91 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acrylonitrile / metabolism*
Adult
Calibration
Female
Gas Chromatography-Mass Spectrometry
Hemoglobins / metabolism*
Humans
Infant, Newborn
Plants, Toxic
Pregnancy
Reference Standards
Smoking / metabolism*
Smoking Cessation*
Tobacco, Smokeless
Chemical
Reg. No./Substance:
0/Hemoglobins; 107-13-1/Acrylonitrile

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Temperature-controlled radiofrequency catheter ablation with a 10-mm tip electrode creates larger le...
Next Document:  Tributyltin-induced apoptosis requires glycolytic adenosine trisphosphate production.